Enhanced antigen immunogenicity induced by bispecific antibodies.
Open Access
- 1 June 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 171 (6), 1957-1963
- https://doi.org/10.1084/jem.171.6.1957
Abstract
The binding protein antigens to APC with heterocrosslinked bispecific antibodies (HBAs) enhances their processing and presentation to Th cells in vitro. Here we have asked whether HBAs could also increase immune responses in vivo. We immunized mice with hen egg lysozyme (HEL) in the presence or absence of HBA, and followed antibody production after the primary challenge and after a secondary boost. We found that HBAs that bind antigen to MHC class I or II molecules, to Fc.gamma.R, but not to surface IgD, enhance the immunogenicity of HEL. HBAs that bound HEL to MHC class II molecules, for examples, decreased the amount of antigen required to elicit a primary anti-HEL antibody response in mice by 300-fold, and the amount required to prime for a secondary response by 103- to 104-fold. In fact, HBAs were as effective as IFA in generating antibody responses. Since adjuvants cannot be used in humans, HBAs could prove useful for immunizing people, especially in cases where, due to scarcity or toxicity, minute doses of antigen must be used.This publication has 24 references indexed in Scilit:
- Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.The Journal of Immunology, 1989
- Delivery of synthetic peptides by anti-class II MHC monoclonal antibodies induces specific adjuvant-free IgG responses in vivoMolecular Immunology, 1988
- Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.Proceedings of the National Academy of Sciences, 1987
- The use of hybrid hybridomas to target human cytotoxic T lymphocytesEuropean Journal of Immunology, 1987
- Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.Proceedings of the National Academy of Sciences, 1986
- Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.The Journal of Experimental Medicine, 1986
- Vaccine AdjuvantsClinical Infectious Diseases, 1980
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979
- Properties of Monoclonal Antibodies to Mouse Ig Allotypes, H-2, and Ia AntigensPublished by Springer Nature ,1979
- Fine specificity of the H‐2 linked immune response gene for the gallinaceous lysozymesEuropean Journal of Immunology, 1975